Sino Biological,Inc. (SHE:301047)
China · Delayed Price · Currency is CNY 76.86
-0.85 (-1.09%)
At close: Jan 22, 2026
Sino Biological,Inc. Market Cap
Sino Biological,Inc. has a market cap or net worth of 9.35 billion as of January 22, 2026. Its market cap has increased by 21.35% in one year.
Market Cap
9.35B
Enterprise Value
6.14B
Revenue
660.17M
Ranking
n/a
PE Ratio
71.49
Stock Price
76.86
Market Cap Chart
Since August 16, 2021, Sino Biological,Inc.'s market cap has decreased from 33.55B to 9.35B, a decrease of -72.13%. That is a compound annual growth rate of -25.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 9.35B | 13.70% |
| Dec 31, 2025 | 8.22B | 9.30% |
| Dec 31, 2024 | 7.52B | -29.33% |
| Dec 29, 2023 | 10.65B | -17.32% |
| Dec 30, 2022 | 12.88B | -45.23% |
| Dec 31, 2021 | 23.51B | -29.92% |
| Aug 16, 2021 | 33.55B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Easton Biopharmaceuticals | 10.28B |
| Bio-Thera Solutions | 10.27B |
| Acrobiosystems | 10.12B |
| Chengzhi | 10.09B |
| Chengdu Kanghua Biological Products | 9.78B |
| Jiangxi Fushine Pharmaceutical | 9.36B |
| Anhui Huaheng Biotechnology | 9.18B |
| Jiangsu Aidea Pharmaceutical Group | 9.05B |